Latest AI and machine learning research in glaucoma for healthcare professionals.
PURPOSE: Predicting the Humphrey Field Analyzer (HFA) 10-2 visual field (VF) using machine learning (ML) based on IMOvifa 24plus(1-2) VF data. DESIGN: Retrospective cross-sectional study. PARTICIPANTS: Seventy actual IMOvifa 24plus(1-2) tests from 25 patients (The Jikei University School of Medicine) and 3472 synthesized IMOvifa 24plus(1-2) tests from 884 patients who underwent HFA 24-2 and HFA 10...
Federated learning (FL) enables collaborative medical image analysis across decentralized institutions while preserving data privacy. However, real-world deployment faces critical challenges: modality heterogeneity, where clients possess incomplete or varying medical image modalities, and cross-disease generalization, requiring models to adapt to unseen pathologies with anatomical consistency. Exi...
Artificial intelligence (AI) has emerged as a transformative force in ophthalmology, enabling automated, accurate, and efficient clinical reporting. T...
Primary open-angle glaucoma (POAG) is one of the most common neurodegenerative diseases that cause irreversible optic nerve damage. POAG diagnosis req...
AIM: To present an overview of the research on global glaucoma treatment in the last decade in terms of publication year, journals, countries/regions,...
PURPOSE OF REVIEW: Emerging biobank resources allow large-scale integration of eye-specific phenotypes with clinical, genomic, and multiomic data. Thi...
PURPOSE: To evaluate the effectiveness and generalizability of bias mitigation methods in glaucoma progression prediction models across a multicenter ...
The 6th Edition of the European Glaucoma Society (EGS) Guidelines delivers a comprehensive, methodologically robust update to one of the most authorit...
Glaucoma is a leading cause of irreversible blindness, driven by progressive Retinal ganglion cell loss and optic nerve degeneration. The molecular me...
Smartphone-based portable slit lamps are rapidly evolving from simple add-ons into practical, low-cost front-line tools for anterior segment care beyo...
Glaucoma remains a critical cause of permanent global visual disability, and is produced by advancing destruction of the visual nerve head (ONH). Earl...
Primary open-angle glaucoma (POAG) screening using artificial intelligence (AI) has emerged as a transformative method to identify undiagnosed disease...
PURPOSE: To evaluate the feasibility and performance of AI-assisted portable fundus photography in children with glaucoma. METHODS: This case series d...
Glaucoma is a common eye disease affecting several people worldwide. Blindness can be avoided with proper treatment and regular examination. Delayed d...
Glaucoma is the leading cause of irreversible blindness worldwide with heterogeneous progression rates. Artificial Intelligence (AI) may enable accura...
In a prior study we demonstrated the strong performance of convolutional neural networks (CNNs) in distinguishing healthy from glaucomatous eyes and s...
Artificial intelligence (AI) holds promise for enhancing glaucoma screening and management, yet its adoption depends on clinician perceptions, particu...
Prostaglandin receptors are pharmacologically validated targets with implications in several medical indications, including glaucoma, cardiac cyanotic...
Glaucoma is a leading cause of irreversible vision loss. During clinical follow-up, visual field (VF) tests (Humphrey Field Analyzer 30-2) assesses fu...
The prevalence of retinal disorders is rising at an alarming rate, posing a significant risk of irreversible blindness without timely intervention. Re...